Drug General Information
Drug ID
D0SH3I
Former ID
DAP001318
Drug Name
Bortezomib
Synonyms
DPBA; PROSCRIPT BORONIC ACID; LPD 341; LDP-341; LPD-341; PS-341; VELCADE (TN); Velcade (TN); Pyz-Phe-boroLeu; Bortezomib(JAN/USAN/INN); Velcade, MG-341, PS-341, Bortezomib; [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid; N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide; Bortezomib (Proteasome inhibitor)
Drug Type
Small molecular drug
Indication Multiple myeloma [ICD9: 203; ICD10:C90] Approved [537129], [541528]
Non-hodgkin's lymphoma; Mantle cell lymphoma [ICD10:C859, C85] Phase 3 [537129], [541528]
Therapeutic Class
Anticancer Agents
Company
Takeda
Structure
Download
2D MOL

3D MOL

Formula
C19H25BN4O4
InChI
InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
InChIKey
GXJABQQUPOEUTA-RDJZCZTQSA-N
CAS Number
CAS 179324-69-7
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:52717
SuperDrug ATC ID
L01XX32
SuperDrug CAS ID
cas=179324697
Drug Resistance Mutation (DRM)
DRM DRM Info
Target and Pathway
Target(s) Proteasome Target Info Modulator [556264]
References
Ref 537129New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21.
Ref 541528(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6391).
Ref 556264Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.